OC
Schedule 13G filing
Orca Capital AG disclosed a 9.9% stake in China SXT Pharmaceuticals, Inc. (SXTC)
Orca Capital AG reported owning 9.9% of China SXT Pharmaceuticals, Inc. (SXTC) (1,112,788 shares) in a Schedule 13G filed Oct 15, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 15, 2026
- Source
- Schedule 13G
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.